CSI Market
Sign In | Register

Regencell Bioscience Holdings Limited (RGC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RGC Annual Balance Sheets →
This balance sheet overview for Regencell Bioscience Holdings Limited spans from Jun 30 2024 to Jun 30 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
0 0 0 (Jun 30 2024)
Assets
Cash & cash equivalent2.42
Short-term Investments, Total2.48
Cash & Short-term Investments4.00
Prepaid Expense, Current AS0.01
Total Current Assets4.90
Equipment/Property/Plant Net0.22
Deposits Assets, Noncurrent AS0.09
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent0.00
Other Assets, Noncurrent0.00
Total Assets5.76
Liabilities
Accrued Liabilities, Current AC0.35
Other Notes Payable, Current OT0.00
Other Liabilities, Current0.31
Total Current Liabilities0.66
Total Long-term Debt0.00
Other liabilities, Noncurrent0.23
Total Liabilities0.90
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock30.12
Retained Earnings / Accumulated Deficit-25.20
Accumulated Other Comprehensive Income0.00
Other Equity-0.06
Common Stockholder's Equity4.86
Total Stockholder's Equity4.86
Liabilities & Stockholder's Equity5.76
4 historic quarters locked

Sign in to unlock the full Regencell Bioscience Holdings Limited balance sheet history.

Sign In Create Free Account

About Regencell Bioscience Holdings Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-25-104686

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.